Zoetis Inc.
ZTSDividend Contender • 12yrsAutomated dividend-safety read-out from payout, leverage, yield, profitability and track record. See the Financials tab for the full per-statement Financial Investigation. Educational only — not investment advice.
At a glance
Zoetis Inc. (ZTS) operates in the Drug Manufacturers - Specialty & Generic industry and is based in the United States. It pays a quarterly dividend of $2.12 a year, a yield of 2.62% at the current price of $81.03. Zoetis has raised its dividend for 12 consecutive years, which makes it a Dividend Contender. Over the last five years the dividend has grown by an average of 20.1% a year. It paid out 34% of its earnings as dividends, leaving most of its profit in the business. 17 analysts cover it; their average 12-month price target of $93.00 is 14.8% above the current price.
Written automatically from the figures on this page, as of Oct 24, 2026. Facts only, not a recommendation.
About Zoetis Inc.
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally. The company commercializes products primarily across companion animals comprising dogs, cats, and horses; and species, including livestock, such as cattle, swine, poultry, fish, and sheep.
Business description sourced from Yahoo Finance / company filings. Not affiliated with SimplyWallStreet.
Key Metrics
Valuation
Profitability
Financial Health
Data provided by Yahoo Finance via yfinance. Updated daily. Not investment advice.